Medicines Company (MDCO-OLD)
Sector: | Health Care |
Super Investor Stats: | |
Ownership count: | 0 |
Ownership rank: | -- |
% of all portfolios: | 0% |
History | Portfolio Manager | Activity ▼ | Share change | % change to portfolio | |
Q1  2020 | |||||
≡ | Lee Ainslie - Maverick Capital | Sell 100.00% | 2,176,487 | 2.69 | |
≡ | David Einhorn - Greenlight Capital | Sell 100.00% | 229,900 | 1.45 | |
≡ | First Eagle Investment Management | Sell 100.00% | 409,112 | 0.10 | |
Q4  2019 | |||||
≡ | Lee Ainslie - Maverick Capital | Reduce 43.96% | 1,707,552 | 2.11 | |
≡ | First Eagle Investment Management | Reduce 46.45% | 354,900 | 0.09 | |
≡ | David Einhorn - Greenlight Capital | Reduce 68.58% | 501,700 | 3.16 | |
Q3  2019 | |||||
≡ | Lee Ainslie - Maverick Capital | Add 0.44% | 16,956 | 0.01 | |
Q2  2019 | |||||
≡ | Lee Ainslie - Maverick Capital | Add 1.38% | 52,731 | 0.03 | |
≡ | David Einhorn - Greenlight Capital | Reduce 22.89% | 217,200 | 0.58 | |
Q1  2019 | |||||
≡ | Lee Ainslie - Maverick Capital | Add 8.52% | 299,375 | 0.11 | |
Q4  2018 | |||||
≡ | Lee Ainslie - Maverick Capital | Add 157.54% | 2,150,140 | 0.61 | |
Q3  2018 | |||||
≡ | Lee Ainslie - Maverick Capital | Add 13.24% | 159,556 | 0.06 | |
≡ | David Einhorn - Greenlight Capital | Reduce 5.12% | 51,200 | 0.06 | |
Q2  2018 | |||||
≡ | Lee Ainslie - Maverick Capital | Add 33.00% | 299,030 | 0.13 | |
Q1  2018 | |||||
≡ | Lee Ainslie - Maverick Capital | Buy | 906,251 | 0.39 | |
Q4  2017 | |||||
≡ | David Einhorn - Greenlight Capital | Buy | 1,000,000 | 0.50 |
* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.